Literature DB >> 21447739

p53 binds to and is required for the repression of Arf tumor suppressor by HDAC and polycomb.

Yaxue Zeng1, Yojiro Kotake, Xin-Hai Pei, Matthew D Smith, Yue Xiong.   

Abstract

The expression of tumor suppressor Arf is tightly repressed during normal cell growth at a young age and is activated by oncogenic insults, and during aging, results in p53 activation and cell-cycle arrest to prevent hyperproliferation. The mechanisms of both transcriptional repression and activation of Arf are not understood. We show that p53 binds to and represses Arf expression and that this repression requires the function of both histone deacetylases (HDAC) and polycomb group (PcG) proteins. Inactivation of p53 leads to increased Arf transcription in both mouse embryonic fibroblasts (MEF) cultured in vitro and in tissues and organs of p53 null mice. Activation of endogenous p53 enhances Arf repression, and reintroduction of p53 back into p53 null MEFs restores Arf repression. Both DNA binding and transactivation activities of p53 are required for Arf repression. We show that p53 is required for both HDAC and PcG to repress Arf expression. Bindings of both HDAC and PcG to Arf are disrupted by inactivation of p53 and can be restored in p53 null MEFs by the reintroduction of wild-type, but not mutant, p53. These results indicate that p53 recruits both HDAC and PcG to Arf locus to repress its expression, and this repression constitutes a second feedback loop in p53 regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21447739      PMCID: PMC3227421          DOI: 10.1158/0008-5472.CAN-10-3483

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  51 in total

1.  Evidence for a negative-feedback mechanism in the biosynthesis of isoleucine.

Authors:  H E UMBARGER
Journal:  Science       Date:  1956-05-11       Impact factor: 47.728

Review 2.  Transcriptional regulation by p53: one protein, many possibilities.

Authors:  O Laptenko; C Prives
Journal:  Cell Death Differ       Date:  2006-06       Impact factor: 15.828

Review 3.  Divorcing ARF and p53: an unsettled case.

Authors:  Charles J Sherr
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

Review 4.  The regulation of INK4/ARF in cancer and aging.

Authors:  William Y Kim; Norman E Sharpless
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

5.  Oncogenic activity of Cdc6 through repression of the INK4/ARF locus.

Authors:  Susana Gonzalez; Peter Klatt; Sonia Delgado; Esther Conde; Fernando Lopez-Rios; Montserrat Sanchez-Cespedes; Juan Mendez; Francisco Antequera; Manuel Serrano
Journal:  Nature       Date:  2006-03-30       Impact factor: 49.962

Review 6.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

7.  Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a.

Authors:  M Murphy; J Ahn; K K Walker; W H Hoffman; R M Evans; A J Levine; D L George
Journal:  Genes Dev       Date:  1999-10-01       Impact factor: 11.361

8.  ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

Authors:  Y Zhang; Y Xiong; W G Yarbrough
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

9.  The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

Authors:  J Pomerantz; N Schreiber-Agus; N J Liégeois; A Silverman; L Alland; L Chin; J Potes; K Chen; I Orlow; H W Lee; C Cordon-Cardo; R A DePinho
Journal:  Cell       Date:  1998-03-20       Impact factor: 41.582

10.  Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

Authors:  T Kamijo; J D Weber; G Zambetti; F Zindy; M F Roussel; C J Sherr
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-07       Impact factor: 11.205

View more
  23 in total

Review 1.  Mechanisms of Yin Yang 1 in oncogenesis: the importance of indirect effects.

Authors:  Michael Atchison; Arindam Basu; Kristina Zaprazna; Madhusudhan Papasani
Journal:  Crit Rev Oncog       Date:  2011

2.  Identification of De Novo Enhancers Activated by TGFβ to Drive Expression of CDKN2A and B in HeLa Cells.

Authors:  Yen-Ting Liu; Lin Xu; Lynda Bennett; Jared C Hooks; Jing Liu; Qinbo Zhou; Priscilla Liem; Yanbin Zheng; Stephen X Skapek
Journal:  Mol Cancer Res       Date:  2019-06-12       Impact factor: 5.852

3.  Human Kruppel-related 3 (HKR3) is a novel transcription activator of alternate reading frame (ARF) gene.

Authors:  Jae-Hyeon Yoon; Won-Il Choi; Bu-Nam Jeon; Dong-In Koh; Min-Kyeong Kim; Myung-Hwa Kim; Jungho Kim; Sujin Susanne Hur; Kyung-Sup Kim; Man-Wook Hur
Journal:  J Biol Chem       Date:  2014-01-01       Impact factor: 5.157

4.  Differential effects on ARF stability by normal versus oncogenic levels of c-Myc expression.

Authors:  Delin Chen; Ning Kon; Jiayun Zhong; Pingzhao Zhang; Long Yu; Wei Gu
Journal:  Mol Cell       Date:  2013-06-06       Impact factor: 17.970

5.  Functional interplay between the DNA-damage-response kinase ATM and ARF tumour suppressor protein in human cancer.

Authors:  Georgia Velimezi; Michalis Liontos; Konstantinos Vougas; Theodoros Roumeliotis; Jirina Bartkova; Maria Sideridou; Ayguel Dereli-Oz; Maciej Kocylowski; Ioannis S Pateras; Kostas Evangelou; Athanassios Kotsinas; Ines Orsolic; Sladana Bursac; Maja Cokaric-Brdovcak; Vassilis Zoumpourlis; Dimitris Kletsas; George Papafotiou; Apostolos Klinakis; Sinisa Volarevic; Wei Gu; Jiri Bartek; Thanos D Halazonetis; Vassilis G Gorgoulis
Journal:  Nat Cell Biol       Date:  2013-07-14       Impact factor: 28.824

6.  Role of p53 in transcriptional repression of SVCT2.

Authors:  Eun Ho Kim; Dong-In Koh; Yea Seong Ryu; Sang-Soo Park; Seung-Woo Hong; Jai-Hee Moon; Jae-Sik Shin; Mi Jin Kim; Do Yeon Kim; Jun Ki Hong; Hong-Rae Jeong; Hyeseon Yun; Joo-Yeon Shin; Joseph Kim; Yoon Sun Park; Dong Min Kim; Dong-Hoon Jin
Journal:  Mol Biol Rep       Date:  2021-02-12       Impact factor: 2.316

7.  p53 restoration kills primitive leukemia cells in vivo and increases survival of leukemic mice.

Authors:  Talía Velasco-Hernández; Carolina Vicente-Dueñas; Isidro Sánchez-García; Dionisio Martin-Zanca
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

8.  ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.

Authors:  Jason T Forys; Catherine E Kuzmicki; Anthony J Saporita; Crystal L Winkeler; Leonard B Maggi; Jason D Weber
Journal:  Cell Rep       Date:  2014-04-13       Impact factor: 9.423

9.  Siva1 inhibits p53 function by acting as an ARF E3 ubiquitin ligase.

Authors:  Xingwu Wang; Meng Zha; Xiaocheng Zhao; Peng Jiang; Wenjing Du; Andrew Y H Tam; Yide Mei; Mian Wu
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma.

Authors:  S E Busch; R D Moser; K E Gurley; K S Kelly-Spratt; H D Liggitt; C J Kemp
Journal:  Oncogene       Date:  2013-06-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.